Rasona, Bb Girl .

HRN: 23-96-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/09/2023
11/16/2023
IV
50mg
Q 24hrs
PSNB; TC Meconium Aspiration
Checking Final Appropriateness 
11/09/2023
AMPICILLIN 1GM (VIAL)
11/09/2023
11/16/2023
IV
169mg
Q12
PSNB; TC Meconium Aspiration
Checking Final Appropriateness 
11/10/2023
CEFOTAXIME 500MG (VIAL)
11/10/2023
11/17/2023
IV
170mg
Q12
Neonatal Sepsis
Checking Final Appropriateness 
11/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/11/2023
11/16/2023
IV
50mg
Q24
Neonatal Sepsis
Checking Final Appropriateness 
11/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/15/2023
11/24/2023
IVT
170mg
Q12
Psnb Meconium Aspiration
Checking Final Appropriateness 
11/15/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
11/15/2023
11/24/2023
IVT
17mg
OD
Psnb Meconium Aspiration
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: